Clinical Trial Update: Evaluate the Safety and Efficacy of AD-35 Tablet in Subjects With Mild to Moderate Alzheimer's Disease [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the safety and efficacy of AD-35 Tablet in patients with Alzheimer’s disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• AD-35 Tablet (AD-35)

Snippet

Sponsor: Zhejiang Hisun Pharmaceutical Co. Ltd. | Conditions: Alzheimer's Disease | Phase 2 | Status: UNKNOWN